These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31927652)

  • 1. Tigecycline for the treatment of patients with Clostridium difficile infection: an update of the clinical evidence.
    Kechagias KS; Chorepsima S; Triarides NA; Falagas ME
    Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1053-1058. PubMed ID: 31927652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is tigecycline a suitable option for Clostridium difficile infection? Evidence from the literature.
    Di Bella S; Nisii C; Petrosillo N
    Int J Antimicrob Agents; 2015 Jul; 46(1):8-12. PubMed ID: 25982915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Tigecycline on C. difficile Outcomes: Case Series and Propensity-Matched Retrospective Study.
    Phillips EC; Warren CA; Ma JZ; Madden GR
    Antimicrob Agents Chemother; 2022 Jun; 66(6):e0000122. PubMed ID: 35647645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of tigecycline for the management of Clostridium difficile colitis in oncology patients and case series of breakthrough infections.
    Brinda BJ; Pasikhova Y; Quilitz RE; Thai CM; Greene JN
    J Hosp Infect; 2017 Apr; 95(4):426-432. PubMed ID: 28153556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and predictors of treatment failure with intravenous tigecycline monotherapy among adult patients with severe Clostridioides (Clostridium) difficile infection: a single-centre observational cohort study.
    Szabo BG; Duma L; Lenart KS; Kiss R; Vad E; Petrik BR; Ostorhazi E; Kadar B
    Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115231. PubMed ID: 33099134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial resistance in Clostridioides (Clostridium) difficile derived from humans: a systematic review and meta-analysis.
    Sholeh M; Krutova M; Forouzesh M; Mironov S; Sadeghifard N; Molaeipour L; Maleki A; Kouhsari E
    Antimicrob Resist Infect Control; 2020 Sep; 9(1):158. PubMed ID: 32977835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridioides difficile associated peritonitis in peritoneal dialysis patients - a case series based review of an under-recognized entity with therapeutic challenges.
    Shah KJ; Cherabuddi K; Pressly KB; Wright KL; Shukla A
    BMC Nephrol; 2020 Mar; 21(1):76. PubMed ID: 32131755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance.
    Shah D; Dang MD; Hasbun R; Koo HL; Jiang ZD; DuPont HL; Garey KW
    Expert Rev Anti Infect Ther; 2010 May; 8(5):555-64. PubMed ID: 20455684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of the murine gastrointestinal microbiota by tigecycline leads to increased susceptibility to Clostridium difficile infection.
    Bassis CM; Theriot CM; Young VB
    Antimicrob Agents Chemother; 2014 May; 58(5):2767-74. PubMed ID: 24590475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The outcome of patients with severe and severe-complicated Clostridium difficile infection treated with tigecycline combination therapy: a retrospective observational study.
    Bishop EJ; Tiruvoipati R; Metcalfe J; Marshall C; Botha J; Kelley PG
    Intern Med J; 2018 Jun; 48(6):651-660. PubMed ID: 29363242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antibiotic to induce Clostridioides difficile-susceptibility and infectious strain in a mouse model of Clostridioides difficile infection and recurrence.
    Castro-Córdova P; Díaz-Yáñez F; Muñoz-Miralles J; Gil F; Paredes-Sabja D
    Anaerobe; 2020 Apr; 62():102149. PubMed ID: 31940467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of intravenous tigecycline in patients with severe Clostridium difficile infection: a retrospective observational cohort study.
    Gergely Szabo B; Kadar B; Szidonia Lenart K; Dezsenyi B; Kunovszki P; Fried K; Kamotsay K; Nikolova R; Prinz G
    Clin Microbiol Infect; 2016 Dec; 22(12):990-995. PubMed ID: 27599690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current state of Clostridium difficile treatment options.
    Venugopal AA; Johnson S
    Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S71-6. PubMed ID: 22752868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridioides difficile infection evaluation and management in the emergency department.
    Carius BM; Liang SY; Koyfman A; Long B
    Am J Emerg Med; 2020 Oct; 38(10):2203-2208. PubMed ID: 33071079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tigecycline for the treatment of severe Clostridium difficile infection.
    Larson KC; Belliveau PP; Spooner LM
    Ann Pharmacother; 2011 Jul; 45(7-8):1005-10. PubMed ID: 21730279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tigecycline for severe Clostridium difficile infection.
    Thomas A; Khan F; Uddin N; Wallace MR
    Int J Infect Dis; 2014 Sep; 26():171-2. PubMed ID: 25064460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriophage endolysins as a potential weapon to combat
    Mondal SI; Draper LA; Ross RP; Hill C
    Gut Microbes; 2020 Nov; 12(1):1813533. PubMed ID: 32985336
    [No Abstract]   [Full Text] [Related]  

  • 18. Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile Infection.
    Britt NS; Steed ME; Potter EM; Clough LA
    Infect Dis Ther; 2014 Dec; 3(2):321-31. PubMed ID: 25466443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).
    McDonald LC; Gerding DN; Johnson S; Bakken JS; Carroll KC; Coffin SE; Dubberke ER; Garey KW; Gould CV; Kelly C; Loo V; Shaklee Sammons J; Sandora TJ; Wilcox MH
    Clin Infect Dis; 2018 Mar; 66(7):e1-e48. PubMed ID: 29462280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on Treatment of Clostridioides difficile Infection.
    Cho JM; Pardi DS; Khanna S
    Mayo Clin Proc; 2020 Apr; 95(4):758-769. PubMed ID: 32247350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.